These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Ischemic preconditioning of the heart can be simulated by pharmacologic hibernation enkephalins]. Karck M; Tanaka S; Oeltgen P; Su TS; Bolling SF; Haverich A Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):1-6. PubMed ID: 14518200 [TBL] [Abstract][Full Text] [Related]
24. Essential role of oxygen radicals in delayed pharmacological preconditioning. Kukreja RC J Mol Cell Cardiol; 2001 Aug; 33(8):1395-8. PubMed ID: 11448128 [No Abstract] [Full Text] [Related]
25. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog. Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386 [TBL] [Abstract][Full Text] [Related]
26. Recovery of left ventricular function after hypothermic global ischemia. Age-related differences in the isolated working rabbit heart. Bove EL; Stammers AH J Thorac Cardiovasc Surg; 1986 Jan; 91(1):115-22. PubMed ID: 3941554 [TBL] [Abstract][Full Text] [Related]
27. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. Shlafer M; Kane PF; Kirsh MM J Thorac Cardiovasc Surg; 1982 Jun; 83(6):830-9. PubMed ID: 7087509 [TBL] [Abstract][Full Text] [Related]
28. Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts. Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA Circulation; 2009 Sep; 120(11 Suppl):S16-21. PubMed ID: 19752362 [TBL] [Abstract][Full Text] [Related]
29. Myocardioprotective effects of the combination of ischemic preconditioning with hypothermia and crystalloid cardioplegia in immature rabbits. Zhu SS; Zhang ZM; Zhang YC; Xu PC; Dong HY; Fan JW; Zeng YM Sheng Li Xue Bao; 2004 Jun; 56(3):389-96. PubMed ID: 15224156 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the antidysrhythmic effects of delta- and kappa-opioid receptor agonists and antagonists on calcium chloride-, adrenaline- and ischemia/reperfusion-induced arrhythmias in rats. Valtchanova-Matchouganska A; Missankov A; Ojewole JA Methods Find Exp Clin Pharmacol; 2004; 26(1):31-8. PubMed ID: 14988739 [TBL] [Abstract][Full Text] [Related]
31. Opiate drugs and delta-receptor-mediated myocardial protection. Benedict PE; Benedict MB; Su TP; Bolling SF Circulation; 1999 Nov; 100(19 Suppl):II357-60. PubMed ID: 10567329 [TBL] [Abstract][Full Text] [Related]
33. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia. Zhu B; Min S; Long C; Ye T Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242 [TBL] [Abstract][Full Text] [Related]
34. Differences in ischemic damage between young and old hearts--Effects of blood cardioplegia. Böning A; Rohrbach S; Kohlhepp L; Heep M; Hagmüller S; Niemann B; Mühlfeld C Exp Gerontol; 2015 Jul; 67():3-8. PubMed ID: 25914110 [TBL] [Abstract][Full Text] [Related]
35. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Lenard NR; Daniels DJ; Portoghese PS; Roerig SC Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633 [TBL] [Abstract][Full Text] [Related]